Daiken Medical Co., Ltd. (TYO:7775)
Japan flag Japan · Delayed Price · Currency is JPY
412.00
+1.00 (0.24%)
Nov 16, 2026, 3:30 PM JST

Daiken Medical Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,0401,2461,5081,4361,0251,151
Depreciation & Amortization
277258232214267314
Loss (Gain) From Sale of Assets
342825281
Other Operating Activities
-345-374-445-436-377-219
Change in Accounts Receivable
-38-99850-99156
Change in Inventory
-223-16177629-122
Change in Accounts Payable
-264-294-126120113-71
Change in Other Net Operating Assets
-69-37-66903-77
Operating Cash Flow
4125671,1201,5559891,133
Operating Cash Flow Growth
-52.09%-49.38%-27.97%57.23%-12.71%86.04%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-423-327-166-162-198-202
Sale (Purchase) of Intangibles
-21--1-6-1-
Other Investing Activities
--3-1--116
Investing Cash Flow
-444-330-168-168-210-196

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-200-80--
Long-Term Debt Issued
-500750-400700
Total Debt Issued
70070075080400700
Short-Term Debt Repaid
---360---
Long-Term Debt Repaid
--489-465-659-604-704
Total Debt Repaid
-379-489-825-659-604-704
Net Debt Issued (Repaid)
321211-75-579-204-4
Common Dividends Paid
-575-660-612-573-565-574
Other Financing Activities
-6-6-9-11-12-11
Financing Cash Flow
-260-455-696-1,163-781-589

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
21--2--1
Net Cash Flow
-290-217256222-2347

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-112409541,393791931
Free Cash Flow Growth
--74.84%-31.51%76.11%-15.04%210.33%
Free Cash Flow Margin
-0.11%2.33%9.59%14.29%8.66%10.90%
Free Cash Flow Per Share
-0.388.3533.2148.4927.5332.41
Levered Free Cash Flow
-218.88169.63776.381,261776.5802.5
Unlevered Free Cash Flow
-207.63177.137821,264778.38804.38

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
181210433
Cash Income Tax Paid
345372443438379218
Change in Working Capital
-594-591-17733646-114